Clinical Trial Update: Appropriate Timing of HAART in Co-infected HIV/TB Patients [Phase 4]

View source ↗

Summary

This update covers a Phase 4 trial evaluating the optimal timing of HAART in patients co-infected with HIV and tuberculosis, which was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• HAART (Highly Active Antiretroviral Therapy)

Snippet

Sponsor: Bamrasnaradura Infectious Diseases Institute | Conditions: HIV Infections, Tuberculosis | Phase 4 | Status: TERMINATED